These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 11302931

  • 1. Metoprolol-paroxetine interaction in human liver microsomes: stereoselective aspects and prediction of the in vivo interaction.
    Hemeryck A, De Vriendt CA, Belpaire FM.
    Drug Metab Dispos; 2001 May; 29(5):656-63. PubMed ID: 11302931
    [Abstract] [Full Text] [Related]

  • 2. Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Hemeryck A, Lefebvre RA, De Vriendt C, Belpaire FM.
    Clin Pharmacol Ther; 2000 Mar; 67(3):283-91. PubMed ID: 10741632
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of metoprolol dosage release formulation on the pharmacokinetic drug interaction with paroxetine.
    Stout SM, Nielsen J, Welage LS, Shea M, Brook R, Kerber K, Bleske BE.
    J Clin Pharmacol; 2011 Mar; 51(3):389-96. PubMed ID: 20400652
    [Abstract] [Full Text] [Related]

  • 5. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6.
    Mautz DS, Nelson WL, Shen DD.
    Drug Metab Dispos; 1995 Apr; 23(4):513-7. PubMed ID: 7600921
    [Abstract] [Full Text] [Related]

  • 6. Effects of paroxetine on the pharmacokinetics and pharmacodynamics of immediate-release and extended-release metoprolol.
    Parker RB, Soberman JE.
    Pharmacotherapy; 2011 Jul; 31(7):630-41. PubMed ID: 21923449
    [Abstract] [Full Text] [Related]

  • 7. Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes.
    Hemeryck A, De Vriendt C, Belpaire FM.
    J Clin Psychopharmacol; 2000 Aug; 20(4):428-34. PubMed ID: 10917404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.
    Otton SV, Crewe HK, Lennard MS, Tucker GT, Woods HF.
    J Pharmacol Exp Ther; 1988 Oct; 247(1):242-7. PubMed ID: 3171974
    [Abstract] [Full Text] [Related]

  • 14. The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
    Stout SM, Nielsen J, Bleske BE, Shea M, Brook R, Kerber K, Welage LS.
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):373-9. PubMed ID: 20705902
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship of paroxetine disposition to metoprolol metabolic ratio and CYP2D6*10 genotype of Korean subjects.
    Yoon YR, Cha IJ, Shon JH, Kim KA, Cha YN, Jang IJ, Park CW, Shin SG, Flockhart DA, Shin JG.
    Clin Pharmacol Ther; 2000 May; 67(5):567-76. PubMed ID: 10824636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat liver microsomes.
    Baune B, Furlan V, Taburet AM, Farinotti R.
    Xenobiotica; 1999 Jun; 29(6):595-601. PubMed ID: 10426558
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.